Narcotics Analgesics Segmentation
Administration Route (Oral, Intravenous, Rectal, Transdermal, Topical)
By 2037, oral segment in narcotics analgesics market is expected to capture remarkable revenue share, attributed to the simple administration through the oral route, the non-invasive nature of administration, and the increased efficiency of these drugs when compared to other routes of administration. Over 80% of drugs in high demand are oral route products with a value of USD 30 billion and a growth rate of 10% annually.
Application (Pain Management, Cough Treatment, Diarrhea)
By 2037, pain management segment in narcotics analgesics market is poised to capture substantial revenue share. Narcotics analgesics are highly used to relieve pain killer, these drugs can be really effective in reducing the pain in the patients suffering from cancer and cardiovascular issues. Therefore, the rising cases of cancer and heart patients is expected to boost the segment growth. According to the World Cancer Research Fund International in 2020, there were 18.1 million new cases of cancer worldwide. 9.3 million of these instances involved men, while 8.8 million involved women. Furthermore, one in fourteen persons worldwide suffers from a heart or circulatory illness. Moreover, according to current estimates, there are around 290 million women and nearly 260 million men suffering from heart and circulation illnesses worldwide.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By Administration Route |
|
